**Core Concept:** Retinoblastoma is a rare cancer of the eye that primarily affects infants and young children. It arises from the retinal cells and is characterized by the uncontrolled proliferation of retinal cells due to genetic mutations. The disease is named after the retina, which is the light-sensitive tissue in the back of the eye.

**Why the Correct Answer is Right:** Retinoblastoma is primarily associated with mutations in the RB1 gene, which is located on chromosome 13q14. The RB1 gene product, the retinoblastoma protein (pRb), plays a crucial role in regulating cell growth and division through the control of the cell cycle. In the absence of functional pRb, as seen in retinoblastoma, the cells fail to undergo cell cycle arrest upon mitogenic stimulation, leading to uncontrolled cell proliferation and the development of the tumor.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because mutations in the Rb1 gene are responsible for the development of retinoblastoma. While other genetic mutations may contribute to the disease, the primary cause is the absence of functional Rb1 protein.

B. This option is incorrect because retinoblastoma primarily affects infants and young children, with a peak incidence between 1 and 3 years of age. While the disease can occur in adults, the term "juvenile" is misleading and does not accurately describe the disease's association with the Rb1 gene mutation.

C. This option is incorrect because retinoblastoma is a rare disease with an estimated incidence of around 1 in 15,000-20,000 live births worldwide. Although the disease is rare, it is a well-known genetic disorder associated with Rb1 gene mutations.

D. This option is incorrect because retinoblastoma is primarily a genetic disease caused by mutations in the Rb1 gene. While external factors like ionizing radiation or chemical exposure may increase the risk of developing retinoblastoma, the disease is primarily a genetic disorder and not solely caused by environmental factors.

**Clinical Pearl:** The RB1 gene and its protein product, pRb, play a critical role in regulating cell cycle progression and preventing uncontrolled cell growth. Mutations in the Rb1 gene lead to the development of retinoblastoma, a rare and aggressive intraocular malignancy in children. Early diagnosis and treatment are essential to improve the survival and visual outcome of affected patients. [1]